Cancer survival rates are typically discussed as 5-year relative survival, or as the proportion of patients alive five years after diagnosis. In the United States, national data shows that in women with ovarian cancer, 46% are still alive five years after diagnosis.
Ovarian cancer survival remains poor due to a number of factors, some of which include: the absence of a reliable screening test, the high number of women diagnosed with late-stage disease, and the tendency for ovarian cancer to eventually resist chemotherapy and recur. Roswell Park researchers are currently working to find solutions to each of these factors.
Patients diagnosed with early-stage disease fare significantly better. Nationally, women with early stage, localized disease, where the cancer is confined to the primary site, 92.5% are still alive five years after diagnosis. Among women whose cancer has spread to regional lymph nodes, the survival rate drops to 74.5%. Women with ovarian cancer that has metastasized to other body areas, called distant disease, have a survival rate of 29.2%. Learn more ovarian cancer statistics from the National Cancer Institute.
After treatment surveillance
We follow national guidelines for evidence-based surveillance to monitor for earliest signs and symptoms of recurrence that includes:
- Physical exams
- Screening with tumor markers
- Monitoring for late side effects of treatment
- Updated information about new strategies and potential clinical trials
Survivorship & Supportive Care Center
This center brings together many of Roswell Park’s clinical and supportive services, specifically designed for patients who have completed active treatment. Our cancer survivorship experts can help:
- Detect and manage any complications or side effects from your disease or its treatment.
- Restore body and soul with rehabilitative therapy, nutrition counseling, and emotional support and guidance.
- Create a plan that will be your roadmap to your healthiest lifestyle possible.